Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dees, E Claire
AVIATOR, NCT03414658: The Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer Mar 2019 - Dec 2019 : From trial for cancer (unspecified)	Active, not recruiting	2	100	US	Vinorelbine, Trastuzumab, Avelumab, Utomilumab	Adrienne G. Waks, Pfizer, Breast Cancer Research Foundation, Johns Hopkins University	Breast Cancer	05/23	05/25
NCT06347068: Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells	Recruiting	1	42	US	iC9-CAR.B7-H3 T Cell Therapy, iC9-CAR.B7-H3 T cells, cyclophosphamide, Cytoxan, fludarabine, Fludara, Fludarabine Phosphate	UNC Lineberger Comprehensive Cancer Center, Bellicum Pharmaceuticals, National Cancer Institute (NCI)	Breast Cancer, Relapse, Resistant Cancer, Triple Negative Breast Cancer	05/26	05/28
Alfaro, Richard
No trials found